Location History:
- Allston, MA (US) (1984 - 1989)
- Westchester, PA (US) (1987 - 1989)
Company Filing History:
Years Active: 1984-1989
Title: Michael J Abrams: Innovator in Radiopharmaceuticals
Introduction
Michael J Abrams is a notable inventor based in Allston, MA (US), recognized for his contributions to the field of radiopharmaceuticals. With a total of five patents to his name, Abrams has made significant advancements in the preparation and application of radiopharmaceutical complexes.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Carboxy, carboalkoxy and carbamile substituted isonitrile radionuclide." This patent describes a coordination complex that includes a radionuclide selected from radioactive isotopes of technetium (Tc), ruthenium (Ru), cobalt (Co), platinum (Pt), and rhenium (Re), along with an isonitrile ligand. Another significant patent is "Method for preparing radiopharmaceutical complexes," which outlines a method for creating radiopharmaceutical complexes that are largely free of the reaction materials used in their production. This method involves mixing a target-seeking ligand, a radionuclide label, and a reducing agent in a suitable solvent, followed by a series of steps to ensure the purity of the final product.
Career Highlights
Michael J Abrams has had a distinguished career, working with prestigious institutions such as Harvard College and the Massachusetts Institute of Technology. His work has focused on enhancing the efficiency and effectiveness of radiopharmaceuticals, contributing to advancements in medical imaging and treatment.
Collaborations
Abrams has collaborated with notable colleagues, including Alun G Jones and Alan L Davison, further enriching his research and development efforts in the field.
Conclusion
Michael J Abrams stands out as an influential inventor in the realm of radiopharmaceuticals, with a strong portfolio of patents that reflect his innovative spirit and dedication to advancing medical science. His contributions continue to impact the field positively.